Research ArticleOriginal Article
Open Access

Epicardial adipose tissue thickness and growth differentiation factor 15 in axial spondyloarthritis

A cross-sectional study

Mehmet Okçu, Fatmanur A. Koçak, Senem Şaş and Kenan Güçlü
Saudi Medical Journal September 2022, 43 (9) 1020-1026; DOI: https://doi.org/10.15537/smj.2022.43.9.20220304

References

  1. 1.↵
    1. Resende GG,
    2. Meirelles EdS,
    3. Marques CDL,
    4. Chiereghin A,
    5. Lyrio AM,
    6. Ximenes AC, et al.
    The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019. Adv Rheumatol 2020; 60: 19.
    OpenUrl
  2. 2.↵
    1. Carli L,
    2. Calabresi E,
    3. Governato G,
    4. Braun J.
    One year in review 2018: axial spondyloarthritis. Clin Exp Rheumatol 2019; 37: 889–898.
    OpenUrl
  3. 3.↵
    1. Baniaamam M,
    2. Heslinga SC,
    3. Konings TC,
    4. Handoko ML,
    5. Kamp O,
    6. van Halm VP, et al.
    Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation. Rheumatol Int 2022; 42: 683–688.
    OpenUrl
  4. 4.↵
    1. Boyraz I,
    2. Onur Caglar S,
    3. Erdem F,
    4. Yazici M,
    5. Yazici S,
    6. Koc B, et al.
    Assessment of relation between neutrophil lympocyte, platelet lympocyte ratios and epicardial fat thickness in patients with ankylosing spondylitis. Med Glas (Zenica) 2016; 13: 14–17.
    OpenUrl
  5. 5.↵
    1. Peters MJ,
    2. Symmons DP,
    3. McCarey D,
    4. Dijkmans BA,
    5. Nicola P,
    6. Kvien TK, et al.
    EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325–331.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Papagoras C,
    2. Voulgari PV,
    3. Drosos AA.
    Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 2013; 31: 612–620.
    OpenUrlPubMed
  7. 7.↵
    1. Al-Ghamdi SH,
    2. Aldosari KH,
    3. AlAjmi MM.
    Patterns and determinants of treatment for coronary artery disease. A cross-sectional study in the Kingdom of Saudi Arabia. Saudi Med J 2021; 42: 895–902.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Yun KH,
    2. Rhee SJ,
    3. Yoo NJ,
    4. Oh SK,
    5. Kim N-H,
    6. Jeong J-W, et al.
    Relationship between the echocardiographic epicardial adipose tissue thickness and serum adiponectin in patients with angina. J Cardiovasc Ultrasound 2009; 17: 121–126.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Jeong JW,
    2. Jeong MH,
    3. Yun KH,
    4. Oh SK,
    5. Park EM,
    6. Kim YK, et al.
    Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71: 9.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Fatma E,
    2. Bunyamin K,
    3. Savas S,
    4. Mehmet U,
    5. Selma Y,
    6. Ismail B, et al.
    Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci 2015; 15: 489–495.
    OpenUrl
  11. 11.↵
    1. Lima-Martínez MM,
    2. Campo E,
    3. Salazar J,
    4. Paoli M,
    5. Maldonado I,
    6. Acosta C, et al.
    Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. Arthritis 2014; 2014: 782850.
    OpenUrl
  12. 12.↵
    1. Tanrıkulu O,
    2. Sarıyıldız MA,
    3. Batmaz İ,
    4. Yazmalar L,
    5. Polat N,
    6. Kaplan İ, et al.
    Serum GDF-15 level in rheumatoid arthritis: relationship with disease activity and subclinical atherosclerosis. Acta Méd Port 2017; 42: 66–72.
    OpenUrl
  13. 13.↵
    1. Brown DA,
    2. Breit SN,
    3. Buring J,
    4. Fairlie WD,
    5. Bauskin AR,
    6. Liu T, et al.
    Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002; 359: 2159–2163.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Guo TM,
    2. Yan Y,
    3. Cao WN,
    4. Liu Q,
    5. Zhu HY,
    6. Yang L, et al.
    Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis. Clin Rheumatol 2018; 37: 1281–1293.
    OpenUrl
  15. 15.↵
    1. Ago T,
    2. Sadoshima J.
    GDF15, a cardioprotective TGF-beta superfamily protein. Circulation research 2006; 98: 294–297.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Song Y,
    2. Cui Y,
    3. Zhang X,
    4. Lin H,
    5. Zhang G,
    6. Zeng H, et al.
    Increased serum levels of MIC1/GDF15 correlated with bone erosion in spondyloarthritis: A pilot study. Medicine (Baltimore) 2018; 97: e13733.
    OpenUrl
  17. 17.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewé R,
    4. Listing J,
    5. Akkoc N,
    6. Brandt J, et al.
    The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777–783.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Calin A,
    2. Nakache JP,
    3. Gueguen A,
    4. Zeidler H,
    5. Mielants H,
    6. Dougados M.
    Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 1999; 38: 878–882.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Chen YH,
    2. Huang WN,
    3. Chen YM,
    4. Lai KL,
    5. Hsieh TY,
    6. Hung WT, et al.
    The BASDAI cut-off for disease activity corresponding to the ASDAS scores in a Taiwanese cohort of ankylosing spondylitis. Front Med (Lausanne) 2022; 9: 856654.
    OpenUrl
  20. 20.↵
    1. van der Heijde D,
    2. Deodhar A,
    3. Fleischmann R,
    4. Mease PJ,
    5. Rudwaleit M,
    6. Nurminen T, et al.
    Early disease activity or clinical response as predictors of long-term outcomes with certolizumab pegol in axial spondyloarthritis or psoriatic arthritis. Arthritis Care Res (Hoboken) 2017; 69: 1030–1039.
    OpenUrl
  21. 21.↵
    1. Calin A,
    2. Garrett S,
    3. Whitelock H,
    4. Kennedy LG,
    5. O’Hea J,
    6. Mallorie P, et al.
    A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281–2285.
    OpenUrlPubMedWeb of Science
  22. 22.↵
    1. Doward LC,
    2. Spoorenberg A,
    3. Cook SA,
    4. Whalley D,
    5. Helliwell PS,
    6. Kay LJ, et al.
    Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20–26.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Jenkinson TR,
    2. Mallorie PA,
    3. Whitelock HC,
    4. Kennedy LG,
    5. Garrett SL,
    6. Calin A.
    Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994; 21: 1694–1698.
    OpenUrlPubMedWeb of Science
  24. 24.↵
    1. Duruöz MT,
    2. Doward L,
    3. Turan Y,
    4. Cerrahoglu L,
    5. Yurtkuran M,
    6. Calis M, et al.
    Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol international. 2013;33:2717–22.
    OpenUrl
  25. 25.
    1. Ozer HTE,
    2. Sarpel T,
    3. Gulek B,
    4. Alparslan ZN,
    5. Erken E.
    The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clinical Rheumatology. 2005;24:123–8.
    OpenUrlPubMed
  26. 26.↵
    1. Akkoc Y,
    2. Karatepe AG,
    3. Akar S,
    4. Kirazli Y,
    5. Akkoc N.
    A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005; 25: 280–284.
    OpenUrlPubMed
  27. 27.↵
    1. Erden Y,
    2. Coskun M,
    3. Sertdemir A,
    4. Ugurlu H.
    Effects of cardiac rehabilitation on cardiac autonomic functions in ankylosing spondylitis patients: A randomized controlled study. Ann Med Res 2021; 28: 1103–1110.
    OpenUrl
  28. 28.↵
    1. Surucu GD,
    2. Yildirim A,
    3. Yetisgin A,
    4. Akturk E.
    Epicardial adipose tissue thickness as a new risk factor for atherosclerosis in patients with ankylosing spondylitis. J Back Musculoskelet Rehabil 2019; 32: 237–243.
    OpenUrl
  29. 29.↵
    1. Kitas GD,
    2. Gabriel SE.
    Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Annals of the rheumatic diseases. 2011;70:8–14.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Gastaldelli A,
    2. Basta G.
    Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc 2010; 20: 481–490.
    OpenUrl
  31. 31.↵
    1. Marchington JM,
    2. Mattacks CA,
    3. Pond CM.
    Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225–232.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Mazurek T,
    2. Zhang L,
    3. Zalewski A,
    4. Mannion JD,
    5. Diehl JT,
    6. Arafat H, et al.
    Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–2466.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Iacobellis G,
    2. Pistilli D,
    3. Gucciardo M,
    4. Leonetti F,
    5. Miraldi F,
    6. Brancaccio G, et al.
    Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251–255.
    OpenUrlPubMedWeb of Science
  34. 34.↵
    1. Lambrecht S,
    2. Coudenys J,
    3. Keyser F,
    4. Verbruggen G,
    5. Deforce D,
    6. Elewaut D.
    Reduced levels of the TGFb family member GDF15 in spondyloarthritis versus other rheumatic diseases. Ann Rheum Dis 2011; 70: A1–A94.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Robertson LP,
    2. Davis MJ.
    A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford) 2004; 43: 1565–1568.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords